Lactoferrin as a Biomarker for the Diagnosis and Prediction of Progression of Lymphoma and Inflammatory Bowel Disease in Dogs

Study Progress Update

Our study into the use of lactoferrin as a means to distinguish between normal dogs and those with IBD or GI Lymphoma is now closed. Preliminary data did not support our hypothesis. Thank you to all those who participated.


If you have questions about your participation in the study or about the study results, please contact:

Ms. Mindy Quigley, Clinical Trials Coordinator
Office Phone: 540-231-1363 | Email: